Imaging and fluid biomarkers in frontotemporal dementia
Imaging and fluid biomarkers in frontotemporal dementia
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Most of the validated biomarkers in frontotemporal dementia (FTD) are used to differentiate patients with FTD from patients with Alzheimer disease or from control individuals
Currently validated biomarkers in FTD include grey matter atrophy, alterations in brain metabolism as detected by
18
F-fluorodeoxyglucose-PET and cerebr...
Alternative Titles
Full title
Imaging and fluid biomarkers in frontotemporal dementia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1910794647
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1910794647
Other Identifiers
ISSN
1759-4758
E-ISSN
1759-4766
DOI
10.1038/nrneurol.2017.75
